Reactivating Mitochondrial Function: a Novel Therapeutic Paradigm for Idiopathic Pulmonary Fibrosis. Using Levothyroxine Nanoparticles in Respirable Powder- LevoNano-IPF
Posted on: 19/01/2026
Deadline: 03/02/2026
Scientific-Disciplinary Group
03/CHEM-08 - Technology, Socioeconomics And Regulation Of Medicinal And Health And Wellbeing Products
Description
The project has the objective of shaping a new therapeutic paradigm for the treatment of idiopathic pulmonary fibrosis through an innovative therapy aimed at reactivating the mitochondrial function of lung epithelial cells using levothyroxine nanoparticles in the form of dry powder for inhalation. Starting from promising preliminary data obtained in vitro with an innovative nanoformulation
Job posting website
Number of positions
1
Funding body
MUR
View the original posting on the MUR website: Go to MUR website